Clinical evidence has revealed altered gut microbiome composition in diabetic patients (de Vos et al., 2022)
When factors such as environment, diet, and medications cause dysbiosis, it can lead to pathogenic bacteria colonizing the intestines, and triggering colonic inflammation through immune modulation, driving the development of UC
However, when combined with insulin or sulfonylureas (in patients with diabetes), the risk of low blood sugar increases significantly, which can manifest as fatigue, weakness, and other symptoms
Behavioral and physiologic responses to caloric restriction in mice
the box limits represent the upper and lower quartiles
These products typically work by reducing the absorption of fat from food, but they come with potential side effects and varying levels of effectiveness